IS8182A - Díarýlmetýlídenpíperídínafleiður, blöndur og notkun þeirra - Google Patents

Díarýlmetýlídenpíperídínafleiður, blöndur og notkun þeirra

Info

Publication number
IS8182A
IS8182A IS8182A IS8182A IS8182A IS 8182 A IS8182 A IS 8182A IS 8182 A IS8182 A IS 8182A IS 8182 A IS8182 A IS 8182A IS 8182 A IS8182 A IS 8182A
Authority
IS
Iceland
Prior art keywords
mixtures
piperidine derivatives
diarylmethylidene piperidine
diarylmethylidene
derivatives
Prior art date
Application number
IS8182A
Other languages
English (en)
Inventor
L. Brown William
Griffin Andrew
Jin Shujuan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0301444A external-priority patent/SE0301444D0/xx
Priority claimed from SE0400024A external-priority patent/SE0400024D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS8182A publication Critical patent/IS8182A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS8182A 2003-05-16 2005-12-14 Díarýlmetýlídenpíperídínafleiður, blöndur og notkun þeirra IS8182A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0301444A SE0301444D0 (sv) 2003-05-16 2003-05-16 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0400024A SE0400024D0 (sv) 2004-01-09 2004-01-09 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
PCT/GB2004/002074 WO2004101522A1 (en) 2003-05-16 2004-05-13 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof

Publications (1)

Publication Number Publication Date
IS8182A true IS8182A (is) 2005-12-14

Family

ID=33455733

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8182A IS8182A (is) 2003-05-16 2005-12-14 Díarýlmetýlídenpíperídínafleiður, blöndur og notkun þeirra

Country Status (15)

Country Link
US (2) US20070099957A1 (is)
EP (1) EP1641757A1 (is)
JP (1) JP2007503457A (is)
KR (1) KR20060010811A (is)
AR (1) AR044346A1 (is)
AU (1) AU2004238618A1 (is)
BR (1) BRPI0410347A (is)
CA (1) CA2525860A1 (is)
CO (1) CO5630032A2 (is)
IS (1) IS8182A (is)
MX (1) MXPA05012117A (is)
NO (1) NO20055998L (is)
RU (1) RU2005136524A (is)
TW (1) TW200512192A (is)
WO (1) WO2004101522A1 (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0203301D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0402485D0 (sv) 2004-10-13 2004-10-13 Astrazeneca Ab Polymorph of N,N-Diethyl-4-(3-Fluorophenyl-Piperidin-4-Ylidene-Methyl)-Benzamide Hydrochloride salt
MY148880A (en) * 2006-10-20 2013-06-14 Astrazeneca Ab N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2898338A (en) * 1954-06-22 1959-08-04 Schering Corp Phenyl, (2-pyridyl)propane derivatives
US2898339A (en) * 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US4581171A (en) * 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US5140029A (en) * 1989-01-09 1992-08-18 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
US4939137A (en) * 1989-06-28 1990-07-03 Ortho Pharmaceutical Corporation Ring-fused thienopyrimidinedione derivatives
US5683998A (en) * 1991-04-23 1997-11-04 Toray Industries, Inc. Tricyclic triazolo derivatives, processes for producing the same and the uses of the same
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
CN1426411A (zh) * 2000-03-03 2003-06-25 奥索-麦克尼尔药品公司 3－(二芳基亚甲基)－8－氮杂双环[3.2.1]辛烷衍生物
US6556387B1 (en) * 2000-03-31 2003-04-29 Seagate Technology Llc Controlling mechanical response characteristics of a disc drive actuator by adjusting a fastener engaging the actuator shaft to vary axial force on the bearing assembly
SE0001208D0 (sv) * 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
SE0001207D0 (sv) * 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
SE0101766D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101768D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101767D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101765D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0103313D0 (sv) * 2001-10-03 2001-10-03 Astrazeneca Ab Novel compounds
SE0203301D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0300104D0 (sv) * 2003-01-16 2003-01-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300103D0 (sv) * 2003-01-16 2003-01-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300105D0 (sv) * 2003-01-16 2003-01-16 Astrazeneca Ab Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0400025D0 (sv) * 2004-01-09 2004-01-09 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0400026D0 (sv) * 2004-01-09 2004-01-09 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
MY148880A (en) * 2006-10-20 2013-06-14 Astrazeneca Ab N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression

Also Published As

Publication number Publication date
AU2004238618A1 (en) 2004-11-25
US20070099957A1 (en) 2007-05-03
NO20055998L (no) 2006-02-13
TW200512192A (en) 2005-04-01
JP2007503457A (ja) 2007-02-22
RU2005136524A (ru) 2006-06-27
BRPI0410347A (pt) 2006-05-30
US20110082173A1 (en) 2011-04-07
MXPA05012117A (es) 2006-02-08
EP1641757A1 (en) 2006-04-05
WO2004101522A1 (en) 2004-11-25
CO5630032A2 (es) 2006-04-28
AR044346A1 (es) 2005-09-07
KR20060010811A (ko) 2006-02-02
CA2525860A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
DK1515969T3 (da) Spiroindolinpiperidinderivater
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
IS8146A (is) Setnar 3-alkýl og 3-alkenýl asetidín afleiður
DK1480955T3 (da) O-cyclopropyl-carboxanilider og deres anvendelse som fungicider
IS7980A (is) Díarýlmetýlídenpíperidínafleiður, framleiðsla þeirra og notkun
NO20054135D0 (no) Kipolinon/benzoksazin derivater og anvendelser derav
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
NO20054136D0 (no) Imidazol-4-yl-etynyl-pyridin-derivater
DK1682493T3 (da) Amidoacetonitrilderivater
IS8040A (is) Arómatískt oxýfenýl og arómatískar súlfanýlfenýl afleiður
ATE352550T1 (de) Chinazolinderivate
NO20054095D0 (no) Pyridyloksymetyl og benzioksazolazabicyklisk derivater
IS8364A (is) N-þíasól-2-ýl-bensamíð afleiður
ATE308543T1 (de) Piperidinderivate
NO20052124D0 (no) Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
IS8045A (is) Púrín-6-ón-afleiður
IS8489A (is) Umritunarstillar og aðferðir þeirra
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
IS7694A (is) Sterasamrunaefnasambönd, framleiðsla og notkun þeirra
ATE449064T1 (de) Amidoacetonitrilderivate
IS7961A (is) Díarýlmetýlídenpíperidínafleiður, lyfjablöndur þeirra og notkun þeirra
IS8182A (is) Díarýlmetýlídenpíperídínafleiður, blöndur og notkun þeirra